|
1. Zaparta JM, Krajewska M,
Krajewski S, Huang RP, Takayama S, Wang HG, Adamson E,
and Reed JR (1998). Expression of multiple apoptosis-regualtory
genes in human breast cancer cell lines and primary
tumors. Breast Can Res &Treat. 47: 129-140.
2. Huang RP, Huang R, Fan Y, and Lin Y (2001). A
novel method for high- throughput protein profiling
from conditioned media and patient’s sera. Ana.
Biochem. 294(1):55-62.
3. Lue JI, and George DL (2007). Hepatic IGFBP1 is
a prosurvival factor that binds to BAK, protects the
liver from apoptosis, and antagonizes the proapoptotic
actions of p53 at mitochondria. Genes & Dev. 21:
3095-3109.
4. Thompson, CB (1995). Apoptosis in the
pathogenesis and treatment of disease. Science. 267
(5203): 1456–62.
5. Brüne B (2003). Nitric oxide: NO apoptosis or
turning it ON? Cell Death Differ. 10 (8): 864–9.
6. Fesik SW, Shi Y (2001). Controlling the caspases.
Science. 294 (5546): 1477–8.
7. Dejean LM, Martinez-Caballero S, Manon S, and
Kinnally KW (2006). Regulation of the mitochondrial
apoptosis-induced channel, MAC, by BCL-2 family
proteins. Biochim. Biophys. Acta. 1762 (2): 191–201.
8. Wajant H (2002). The Fas signaling pathway: more
than a paradigm. Science. 296 (5573): 1635–6.
9. Chen G, and Goeddel DV (2002). TNF-R1 signaling:
a beautiful pathway. Science. 296 (5573): 1634–5.
10. Murphy KM, Ranganathan V, Farnsworth ML,
Kavallaris M, and Lock RB ( 2000). Bcl-2 inhibits Bax
translocation from cytosol to mitochondria during
drug-induced apoptosis of human tumor cells. Cell
Death Differ. 7 (1): 102–11.
11. Susin SA, Lorenzo HK, and Zamzami N (1999).
Molecular characterization of mitochondrial
apoptosis-inducing factor. Nature. 397 (6718): 441–6.
12. Nagata S (2000). Apoptotic DNA fragmentation.
Exp. Cell Res. 256 (1): 12–8.
|